MicroRNAs are non-coding RNAs that serve as regulatory molecules in a variety of pathways such as inflammation, metabolism, homeostasis, cell machinery, and …
X Liu, J Li, BL Cadilha, A Markota, C Voigt, Z Huang… - Science …, 2019 - science.org
Carcinoma cells undergo epithelial-mesenchymal transition (EMT); however, contributions of EMT heterogeneity to disease progression remain a matter of debate. Here, we …
WB Yin, MG Yan, X Fang, JJ Guo, W Xiong… - Clinica chimica acta, 2018 - Elsevier
Abstract Background Circular RNAs (circRNAs) are a class of non-coding RNAs (ncRNAs) and characterized by covalently closed loop without 5′ and 3′ end. Recently, the …
J Chen, X Zhang, J Zhang, Z Wang, G Zhu… - Journal of Controlled …, 2024 - Elsevier
Metastatic recurrence and postoperative wound infection are two major challenges for breast cancer patients. In this study, a multifunctional responsive hydrogel system was …
The great advances in the studies on metal complexes for the treatment of different cancer forms, starting from the pioneering works on platinum derivatives, have fostered an …
X Shi, Y Cheng, J Wang, H Chen, X Wang, X Li… - Theranostics, 2020 - ncbi.nlm.nih.gov
Rationale: Tumors are commonly treated by resection, which usually leads to massive hemorrhage and tumor cell residues, thereby increasing the risk of local recurrence and …
T Capeloa, J Krzystyniak, D d'Hose… - Cancers, 2022 - mdpi.com
Simple Summary Solid tumors comprise metabolically hostile areas adjacent to metabolically friendly ones, and their distribution fluctuates in space and time. Selection …
W Du, Z Zhu, X Jiang, M Kang, D Pei - Acta Pharmacologica Sinica, 2023 - nature.com
Due to poor T cell infiltration, tumors evade immune surveillance. Increased CD8+ T cell infiltration in breast cancer suggests a satisfactory response to immunotherapy. COPS6 has …
J Shin, B Kim, TW Lager, F Mejia, I Guldner, C Conner… - Nanoscale, 2023 - pubs.rsc.org
Here, rational engineering of doxorubicin prodrug loaded peptide-targeted liposomal nanoparticles to selectively target metastatic breast cancer cells in vivo is described …